Amide linker peroxisome proliferator activated receptor modulators

Details for Australian Patent Application No. 2003241579 (hide)

Owner Eli Lilly and Company

Inventors Martin, Jose Alfredo; Ferritto Crespo, Rafael; Xu, Yanping; SHEN, Quanrong; Martin-Ortega, Finger Maria Dolores; Warshawsky, Alan M.; ROJO GARCIA, Isabel

Agent Spruson & Ferguson

Pub. Number AU-B-2003241579

PCT Number PCT/US03/16207

PCT Pub. Number WO2004/000789

Priority 60/390,102 19.06.02 US

Filing date 11 June 2003

Wipo publication date 6 January 2004

Acceptance publication date 19 March 2009

International Classifications

C07D 295/18 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/192 (2006.01)

A61K 31/216 (2006.01)

A61K 31/22 (2006.01)

A61K 31/36 (2006.01)

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61K 31/433 (2006.01) - Thiadiazoles

A61K 31/4402 (2006.01) - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/472 (2006.01) - Non-condensed isoquinolines, e.g. papaverine

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/08 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07C 69/734 (2006.01) Esters of carboxylic acids

C07C 233/18 Carboxylic acid amides

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 60/390,102 19.06.02 US

4 March 2004 Application Open to Public Inspection

  Published as AU-B-2003241579

19 March 2009 Application Accepted

  Published as AU-B-2003241579

16 July 2009 Standard Patent Sealed

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003241580-Anti-IGF-I receptor antibody

2003241578-RECHARGING SYSTEM FOR A REMOTE CAPACITIVE SENSING APPARATUS